Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
Clinical trial NCT03737955 · RECRUITING
Trial details
- NCT number
- NCT03737955
- Sponsor
- University of Washington
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2026-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.